NALF2 (NALCN channel auxiliary factor 2)
|
Gene
Gene information from NCBI Gene database.
|
|
| Entrez ID | 27112 |
| Gene name | NALCN channel auxiliary factor 2 |
| Gene symbol | NALF2 |
| Synonyms (NCBI Gene) |
CXorf63FAM155BTEDTMEM28bB57D9.1
|
| Chromosome | X |
| Chromosome location | Xq13.1 |
| Summary | This gene encodes a product belonging to a family of proteins with unknown function. The presence of two transmembrane domains suggests that this protein is a multi-pass membrane protein. [provided by RefSeq, Sep 2011] |
|
Gene ontology (GO)
Gene Ontology (GO) annotations describing the biological processes, molecular functions, and cellular components associated with a gene.
4
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Other IDs
Other IDs provides unique identifiers for this gene in OMIM, HGNC, and Ensembl databases.
|
|||||||
|
|||||||
|
Protein
Protein information from UniProt database.
|
||
|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
O75949 | |
| Protein name | NALCN channel auxiliary factor 2 (Protein TED) (Transmembrane protein 28) (Transmembrane protein FAM155B) | |
| Protein function | Probable component of the NALCN channel complex, a channel that regulates the resting membrane potential and controls neuronal excitability. | |
| Family and domains | ||
| Sequence |
|
|
| Sequence length | 472 | |
| Interactions | View interactions | |
|
Associated diseases
Disease associations from ClinVar (causal & non-causal) and other databases (OMIM, Orphanet, GWAS, etc.).
2
|
|||||||||||||||||||||||||||||||||||||
|
Evidence Score:
★☆☆☆☆ Gene-disease association found in Text Mining only
★★☆☆☆ Found in Text Mining and Unknown/Other Associations
★★★☆☆ Reported in Unknown/Other Associations across ≥2 Sources
★★★★☆ ClinVar: Pathogenic/Likely Pathogenic (<5 Variants)
★★★★★ ClinVar: Pathogenic/Likely Pathogenic (≥5 Variants)
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||